State Of Wisconsin Investment Board Chimerix Inc Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $8,456 - $12,894	-4,672 Reduced 23.32%	15,359 $30,000
Q2 2022 Aug 15, 2022	SELL	$1.34 - $5.34 $180,724 - $720,200	-134,869 Reduced 87.07%	20,031 $42,000
Q1 2022 May 13, 2022	BUY	$4.58 - $6.8 $170,834 - $253,640	37,300 Added 31.72%	154,900 $709,000
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $46,332 - $68,250	7,800 Added 7.1%	117,600 $728,000
Q2 2021 Aug 12, 2021	BUY	$7.54 - $9.79 $69,368 - $90,067	9,200 Added 9.15%	109,800 $878,000
Q1 2021 May 17, 2021	BUY	$4.76 - $11.25 $155,176 - $366,750	32,600 Added 47.94%	100,600 $970,000
Q4 2020 Feb 03, 2021	BUY	$2.43 - $5.42 $165,240 - $368,560	68,000 New	68,000 $328,000
Q2 2019 Aug 14, 2019	SELL	$2.05 - $4.32 $122,794 - $258,768	-59,900 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$1.79 - $3.12 $24,523 - $42,744	13,700 Added 29.65%	59,900 $126,000
Q4 2018 Feb 11, 2019	BUY	$2.24 - $3.9 $27,328 - $47,580	12,200 Added 35.88%	46,200 $119,000
Q3 2017 Nov 01, 2017	BUY	$4.35 - $5.25 $147,900 - $178,500	34,000	34,000 $178,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.